The Study of AZD8529 for Smoking Cessation in Female Smokers

PHASE2CompletedINTERVENTIONAL
Enrollment

214

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

January 31, 2017

Conditions
Tobacco Use Disorder
Interventions
DRUG

AZD8529

comparison of different dosages of drug

Trial Locations (9)

10019

Columbia University Medical Center, New York

19104

Centers for the Studies of Addiction, Philadelphia

20742

University of Maryland - College Park, College Park

23219

Virginia Commonwelath University, Richmond

45229

University of Cincinnati, Cincinnati

90720

Pharmacology Research Institute, Los Alamitos

91316

Pharmacology Research Institute, Encino

92037

Pacific Treatment and Research Center, La Jolla

92660

Pharmacology Research Institute, Newport Beach

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT02401022 - The Study of AZD8529 for Smoking Cessation in Female Smokers | Biotech Hunter | Biotech Hunter